BioSpace News Archive

Clinical Trial Imaging Market: Increase in the biotechnology and pharmaceutical industries is fueling the growth of the market

Medical imaging plays a prominent role in clinical trials as it can help in providing answers to the critical challenges that occur in drug development process.

September 23, 2020
·
6 min read
Angle PLC Announces Potential Treatment Strategy to Limit Metastasis

Published research using the Parsortix system to isolate CTC clusters from blood confirms the role of intra-tumour hypoxia in promoting metastatic breast cancer

September 23, 2020
·
8 min read
Policy

GW Pharmaceuticals receives Australian Therapeutic Goods Administration (TGA) approval for EPIDYOLEX® (cannabidiol) for the treatment of seizures in patients with two rare, severe forms of childhood-onset epilepsy

This represents the third successful regulatory approval globally for GW’s plant-derived cannabis-based medicine

September 23, 2020
·
5 min read
Policy

bluebird bio’s LentiGlobin™ for Sickle Cell Disease Gene Therapy (bb1111) Granted Priority Medicines (PRIME) Designation by European Medicines Agency

EMA’s PRIME program designed to optimize development and expedite evaluation of innovative medicines for patients with high unmet need

September 23, 2020
·
6 min read
Policy

New Treatment for Urethral Strictures, Optilume®, Receives CE Approval

Urotronic’s Drug Coated Balloon Provides Minimally-Invasive, Durable Alternative for Stricture Patients in Europe

September 23, 2020
·
3 min read
Lexaria Receives Orders for 4.4 Million Servings of DehydraTECH-Enabled CBD Powders

Lexaria Bioscience Corp. is pleased to announce that it is in receipt of purchase-order commitments for approximately 4.4 million CBD servings of its patented DehydraTECHTM enabled CBD powders,

September 23, 2020
·
5 min read
Pharm Country

Sun Pharmaceutical Industries, Inc. Issues Voluntary Nationwide Recall of RIOMET ER™ (metformin hydrochloride for extended-release oral suspension) Due to N-Nitrosodimethylamine (NDMA) Content Above the Acceptable Daily Intake (ADI) Limit

Sun Pharmaceutical Industries, Inc., a wholly owned subsidiary of Sun Pharmaceutical Industries Ltd. is voluntarily recalling one lot of RIOMET ER™, 500 mg per 5 mL to the consumer level.

September 23, 2020
·
3 min read
BioCapital

Seven Million American Women of Childbearing Age Live in Counties with Limited or No Maternity Care, Contributing to Maternal and Infant Health Crisis, Finds New March of Dimes Report

Organizations nationwide support #BlanketChange by demanding equity, access and prevention to improve the health of moms & babies

September 23, 2020
·
6 min read
Personalized Medicine Market | Next Generation Sequencing to Shoot Up Demand for Personalized Medicines

Personalized medicines refer to those drugs that are made on the basis of intended patient groups or an individual patient carrying specific biomarkers.

September 23, 2020
·
3 min read
Drug Development

Veeva and Bioforum Partner with RedHill Biopharma to Maximize Value of Opaganib Phase 2/3 COVID-19 Clinical Data

Veeva Vault CDMS and Bioforum selected to optimize clinical data management for RedHill’s global Phase 2/3 clinical trial evaluating opaganib in patients with severe COVID-19

September 23, 2020
·
14 min read